PL2436275T3 - Kompozycja lipidowa dla poprawy funkcji mózgu - Google Patents

Kompozycja lipidowa dla poprawy funkcji mózgu

Info

Publication number
PL2436275T3
PL2436275T3 PL11195555T PL11195555T PL2436275T3 PL 2436275 T3 PL2436275 T3 PL 2436275T3 PL 11195555 T PL11195555 T PL 11195555T PL 11195555 T PL11195555 T PL 11195555T PL 2436275 T3 PL2436275 T3 PL 2436275T3
Authority
PL
Poland
Prior art keywords
brain function
lipid composition
improving brain
lipid fraction
acid
Prior art date
Application number
PL11195555T
Other languages
English (en)
Inventor
Robert Johan Joseph Hageman
Der Beek Eline Marleen Van
Martine Groenendijk
Patrick Joseph Gerardus Hendrikus Kamphuis
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38457798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2436275(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2436275T3 publication Critical patent/PL2436275T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL11195555T 2007-06-26 2008-06-20 Kompozycja lipidowa dla poprawy funkcji mózgu PL2436275T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2007/050306 WO2009002145A1 (en) 2007-06-26 2007-06-26 Lipid composition for improving function of brain functioning
EP08766833A EP2162019B1 (en) 2007-06-26 2008-06-20 Lipid composition for improving brain function
EP11195555.5A EP2436275B1 (en) 2007-06-26 2008-06-20 Lipid composition for improving brain function

Publications (1)

Publication Number Publication Date
PL2436275T3 true PL2436275T3 (pl) 2013-12-31

Family

ID=38457798

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08766833T PL2162019T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa do poprawy czynności mózgu
PL11195555T PL2436275T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa dla poprawy funkcji mózgu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL08766833T PL2162019T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa do poprawy czynności mózgu

Country Status (11)

Country Link
US (2) US8283335B2 (pl)
EP (2) EP2436275B1 (pl)
CN (1) CN101742926B (pl)
AT (1) ATE538665T1 (pl)
BR (1) BRPI0813320B1 (pl)
DK (1) DK2436275T3 (pl)
ES (2) ES2378176T3 (pl)
PL (2) PL2162019T3 (pl)
PT (2) PT2162019E (pl)
WO (2) WO2009002145A1 (pl)
ZA (1) ZA200909230B (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
NZ599748A (en) * 2007-06-26 2013-11-29 Nutricia Nv Improving memory in subjects with mini-mental state examination of 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
ES2664777T5 (es) † 2007-10-04 2021-10-25 Nestle Sa Composiciones y procedimientos para mejorar la función cognitiva
EP2222311B1 (en) 2007-12-20 2013-03-27 N.V. Nutricia Liquid nucleotides/nucleosides-containing product
PL3002881T5 (pl) * 2008-02-01 2022-10-03 Guangdong Oppo Mobile Telecommunications Corp., Ltd. Układ i sposób synchronizacji taktowania dla łącza w górę w połączeniu z nieciągłym odbiorem
CA2751275A1 (en) * 2009-02-02 2010-08-05 Martek Biosciences Corporation Use of docosahexaenoic acid in treating mild cognitive impairment
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
JP5920890B2 (ja) 2010-01-19 2016-05-18 ディーエスエム アイピー アセッツ ビー．ブイ． エイコサペンタエン酸生成微生物、脂肪酸組成物、ならびにそれらを作る方法およびそれらの使用
SG10201707519PA (en) * 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
WO2012125020A1 (en) 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US9222112B2 (en) * 2011-07-21 2015-12-29 Dsm Ip Assets B.V. Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
US20150044138A1 (en) * 2012-03-02 2015-02-12 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013129914A1 (en) 2012-03-02 2013-09-06 N.V. Nutricia Method for improving functional synaptic connectivity
US20140256813A1 (en) * 2013-03-08 2014-09-11 Nordic Naturals, Inc. Methods for the treatment of brain injury using omega-3 fatty acids
WO2014171813A1 (en) 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
EP3027063B1 (en) * 2013-08-01 2018-11-21 Bunge Loders Croklaan B.V. Opo glyceride composition
WO2015034984A1 (en) * 2013-09-05 2015-03-12 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
WO2015084158A1 (en) * 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
WO2015115885A1 (en) 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
JPWO2016010102A1 (ja) * 2014-07-17 2017-04-27 日清オイリオグループ株式会社 栄養組成物
EP3173089B1 (en) * 2014-07-23 2023-10-25 The Food Science Institute Foundation Agent for improving brain function and agent for preventing cognitive impairment
WO2016053085A1 (en) * 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
CN104305192B (zh) * 2014-10-23 2016-05-04 贡岳松 改善老年痴呆症患者记忆的功能性食品及其制备方法
WO2016148561A1 (en) 2015-03-16 2016-09-22 N.V. Nutricia Method for improving bladder function
CA2908184C (en) 2015-10-13 2019-10-22 Roto-gro Inc. Stackable modular rotatable gardening system
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
CA3004996A1 (en) * 2015-12-04 2017-06-08 Nestec S.A. Method for improving cognition
JP6256888B2 (ja) * 2016-02-29 2018-01-10 高知県公立大学法人 健脳食品または健脳飲料およびこれらを投与する方法
WO2017155387A1 (en) 2016-03-08 2017-09-14 N.V. Nutricia Method for supporting memory function and/or cognitive function
AU2016401061A1 (en) * 2016-03-30 2018-08-16 Société des Produits Nestlé S.A. Nutritional compositions and their use
CN109310662A (zh) * 2016-04-18 2019-02-05 N·V·努特里奇亚 用于减少生命早期应激诱导的认知下降/神经发生减少的亚油酸和α-亚麻酸
WO2017183956A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline
US20180085331A1 (en) * 2016-09-26 2018-03-29 Garrett E. Wdowin Compositions for mitigating head trauma
US10456368B2 (en) 2016-09-26 2019-10-29 Garrett E. Wdowin Compositions for mitigating brain trauma and methods thereof
HUE052258T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Megasphaera nemzetségbe tartozó baktériumtörzset tartalmazó készítmény, és alkalmazása
JP7515407B2 (ja) * 2018-06-21 2024-07-12 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ニコチンアミドアデニンジヌクレオチド（ｎａｄ＋）前駆体及び少なくとも１種のケトン又はケトン前駆体を使用する組成物及び方法
WO2020014051A1 (en) * 2018-07-09 2020-01-16 Wdowin Garrett E Compositions for mitigating brain trauma and methods thereof
CN117956908A (zh) 2021-09-17 2024-04-30 N·V·努特里奇亚 适合作为营养组合物或补充剂用于患有脑相关障碍、衰退或疾病的动物的固体组合物

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JP2525624B2 (ja) * 1987-09-21 1996-08-21 雪印乳業株式会社 多価不飽和脂肪酸配合育児用粉乳
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
US5378488A (en) 1993-06-10 1995-01-03 Abbott Laboratories Aseptic processing of infant formula
JP3576318B2 (ja) 1996-06-19 2004-10-13 明治乳業株式会社 核酸関連物質含有栄養組成物
JPH10136937A (ja) * 1996-11-08 1998-05-26 Takashi Morita 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品
PT843972E (pt) 1996-11-20 2002-12-31 Nutricia Nv Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20070004670A1 (en) 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
FR2787799B1 (fr) 1998-12-23 2001-03-09 Rhodia Chimie Sa Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
PT1390378E (pt) 2001-04-30 2009-07-23 Trommsdorff Arzneimittel Ésteres de uridina farmaceuticamente activos
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030114415A1 (en) 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
ES2309901T3 (es) 2003-10-24 2008-12-16 N.V. Nutricia Oligosacaridos inmunomoduladores.
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2566612C (en) 2004-05-13 2015-06-30 Massachusetts Institute Of Technology Uridine effects on dopamine release
JP2008513453A (ja) 2004-09-15 2008-05-01 マサチューセッツ インスティテュート オブ テクノロジー ウリジンを含んだ組成物及びその使用方法
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
EP1888081B1 (en) 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
EP1915144A4 (en) 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
BRPI0613358A8 (pt) 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
WO2007058523A1 (en) 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
NZ599748A (en) 2007-06-26 2013-11-29 Nutricia Nv Improving memory in subjects with mini-mental state examination of 24-26
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
EP2222311B1 (en) 2007-12-20 2013-03-27 N.V. Nutricia Liquid nucleotides/nucleosides-containing product
JP5397321B2 (ja) 2009-06-09 2014-01-22 株式会社デンソー 駐車支援システム

Also Published As

Publication number Publication date
ATE538665T1 (de) 2012-01-15
EP2162019B1 (en) 2011-12-28
EP2162019A1 (en) 2010-03-17
US8283335B2 (en) 2012-10-09
PL2162019T3 (pl) 2012-05-31
WO2009002165A1 (en) 2008-12-31
US20110009357A1 (en) 2011-01-13
PT2162019E (pt) 2012-03-20
ES2432345T3 (es) 2013-12-02
CN101742926B (zh) 2017-06-09
ZA200909230B (en) 2010-09-29
CN101742926A (zh) 2010-06-16
BRPI0813320B1 (pt) 2018-08-07
DK2436275T3 (da) 2013-10-28
ES2378176T3 (es) 2012-04-09
EP2436275B1 (en) 2013-07-24
US8759319B2 (en) 2014-06-24
PT2436275E (pt) 2013-10-31
WO2009002145A1 (en) 2008-12-31
BRPI0813320A2 (pt) 2015-01-06
US20130018012A1 (en) 2013-01-17
EP2436275A1 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
PL2162019T3 (pl) Kompozycja lipidowa do poprawy czynności mózgu
WO2008036353A3 (en) Omega-3 diglyceride emulsions
ZA200909227B (en) Food composition for prodromal dementia patients
GB2459809A (en) Fatty acid formulations and methods of use thereof
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
EP1928262A4 (en) METHODS FOR EXTENDING THE LIFETIME OF FOOD COMPOSITIONS CONTAINING POLY-UNSATURATED FATTY ACIDS
MX2009004339A (es) Alcoholes de acido graso.
MX286464B (es) Formulaciones de acido graso omega 3.
HRP20130811T1 (en) Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia
WO2008129358A8 (en) Oil producing microbes and methods of modification thereof
HRP20130531T1 (en) Method for producing a concentrate of eicosapentaenoic and docosahexaenoic acid esters
WO2011097273A8 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
MY163414A (en) Fat and oil composition and chocolate product using the same
PL1706106T3 (pl) Zastosowanie wysoko stężonych kompozycji wybranych kwasów tłuszczowych n-3 do leczenia zaburzeń ośrodkowego układu nerwowego
EP1958612A4 (en) TREHALOSE FATTY ACID ESTER COMPOSITION
ATE422350T1 (de) Anisinsäure und glyceride enthaltende zusammensetzungen
MY161118A (en) Use of methanesulfonic acid for producing fatty acid esters
PL2214628T3 (pl) Kompozycja ulegająca rozpadowi w jamie ustnej, zawierająca wielonienasycone kwasy tłuszczowe bez przykrej woni lub smaku
MX2011010935A (es) Composicion basada en petrolato comprendido mas de 10%de silicon para sensacion mejorada al tiempo que permanece estable.
ATE258435T1 (de) Pinolensäure gegen diabetes
ATE521250T1 (de) Immunostimulierende nahrungsmittel
DE602006013755D1 (de) Fettlösliche Drogengestaltung
WO2007135518A3 (en) Use of choline-based preparations for the treatment of tinnitus
ATE415151T1 (de) Formulierung zur verzögerten freisetzung von valproinsäure und deren derivate
FR2896172B1 (fr) Nouveau procede de stabilisation des acides gras polyinsatures et les compositions ainsi obtenus.